Lisata Therapeutics, Inc. (LSTA)

Price & Market Data

Price: $3.26

Daily Change: $0.00 / 0.00%

Daily Range: $3.20 - $3.38

Market Cap: $29,686,834

Daily Volume: 15,291

Performance Metrics

1 Week: -0.31%

1 Month: -34.67%

3 Months: -28.19%

6 Months: 58.25%

1 Year: 46.53%

YTD: 75.27%

About Lisata Therapeutics, Inc. (LSTA)

Keep track of Lisata Therapeutics, Inc. (LSTA)'s market journey. Priced at 3.26, the stock reflects a daily movement of $0.00 / 0.00%. With a market cap of 29,686,834, explore its full spectrum of performance from YTD to 1-year.

Company Details

Employees: 21

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Selected stocks

Bluerock Homes Trust, Inc. (BHM)

Cytosorbents Corporation (CTSO)

RB Global, Inc. (RBA)

Cameco Corporation (CCJ)

Tyra Biosciences, Inc. (TYRA)